Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$115.29
-5.55%
Mkt Cap $9.69B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
Implied Upside
+8.7%
Consensus $125.29 vs current $115.29
NASDAQ·Healthcare·Biotechnology
$115.29
-5.55%
Mkt Cap $9.69B
Buy
13
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
+8.7%
Consensus $125.29 vs current $115.29